Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Viracta Therapeutics Ord Shs (VIRX)  
$0.76 0.07 (7.88%) as of 4:30 Fri 5/10


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 37,090,000
Market Cap: 28.19(M)
Last Volume: 1,764,528 Avg Vol: 1,759,649
52 Week Range: $0.439 - $2.125
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Viracta Therapeutics is a precision oncology company focused on the development of medicines targeting virus-associated malignancies. Co.'s main program is focused on cancers associated with the Epstein-Barr virus (EBV). Co.'s main product candidate is an all-oral combination therapy of its investigational drug, nanatinostat and the antiviral agent valganciclovir (collectively referred to as Nana-val). Nana-val is being investigated in clinical trials, including NAVAL-1, a trial for the treatment of multiple subtypes of relapsed/refractory EBV-positive (EBV+) lymphoma, as well as a trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 100,000 100,000 100,000
Total Buy Value $0 $49,361 $49,361 $49,361
Total People Bought 0 1 1 1
Total Buy Transactions 0 2 2 2
Total Shares Sold 3,405 7,125 14,272 63,811
Total Sell Value $2,493 $4,353 $14,605 $152,715
Total People Sold 1 1 1 3
Total Sell Transactions 1 2 4 14
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 163
  Page 4 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Misfeldt Dayton Director   –       •      –    2017-10-27 4 B $2.00 $800,000 I/I 400,000 30,456 2.1     -
   Parker Geoffrey M. Director   –       •      –    2016-12-09 4/A B $3.90 $2,318 D/D 594 14,074 2.31     -
   Parker Geoffrey M. Director   –       •      –    2016-12-09 4 B $3.90 $2,318 D/D 594 65,745 2.31     -
   Parker Geoffrey M. Director   –       •      –    2016-12-08 4/A B $3.87 $12,159 D/D 3,146 13,480 2.39     -
   Parker Geoffrey M. Director   –       •      –    2016-12-08 4 B $3.87 $12,159 D/D 3,146 65,151 2.39     -
   Parker Geoffrey M. Director   –       •      –    2016-05-26 4 B $0.47 $4,455 D/D 9,500 62,005 2.31     -
   Parker Geoffrey M. Director   –       •      –    2016-05-25 4 B $0.49 $10,933 D/D 22,505 52,505 2.39     -
   Parker Geoffrey M. Director   –       •      –    2016-05-24 4 B $0.46 $13,881 D/D 30,000 30,000 2.39     -
   Bjerkholt Eric EVP, CFO & Corp. Secretary   •       –      –    2016-02-29 4 D $0.75 $26,243 D/D (34,991) 100,922     -
   Bjerkholt Eric EVP, CFO & Corp. Secretary   •       –      –    2016-02-29 4 A $0.00 $0 D/D 80,000 135,913     -
   Swisher Daniel N Jr President and CEO   •       •      –    2016-02-29 4 D $0.75 $41,756 D/D (55,675) 266,519     -
   Swisher Daniel N Jr President and CEO   •       •      –    2016-02-29 4 A $0.00 $0 D/D 137,533 322,194     -
   Misfeldt Dayton Director   –       •      –    2015-12-21 4 B $0.84 $1,470,000 I/I 1,750,000 137,859 2.1     -
   Swisher Daniel N Jr President and CEO   •       •      –    2015-08-25 4 B $1.01 $12,338 I/I 12,216 199,736 2.58     -
   Swisher Daniel N Jr President and CEO   •       •      –    2015-08-24 4 B $1.01 $12,912 I/I 12,784 187,520 2.58     -
   Misfeldt Dayton Director   –       •      –    2015-07-24 4 S $3.46 $2,200,242 I/I (635,702) 105,134     -
   Misfeldt Dayton Director   –       •      –    2015-07-24 4 OE $1.32 $2,198,896 I/I 1,665,830 109,096     -
   Bjerkholt Eric EVP, CFO & Corp. Secretary   •       –      –    2015-07-24 4 S $3.46 $21,989 I/I (6,358) 83,827     -
   Bjerkholt Eric EVP, CFO & Corp. Secretary   •       –      –    2015-07-24 4 OE $1.32 $21,986 I/I 16,656 85,946     -
   Swisher Daniel N Jr President and CEO   •       •      –    2015-07-24 4 B $1.02 $25,458 I/I 25,000 174,336 2.66     -
   Swisher Daniel N Jr President and CEO   •       •      –    2015-07-24 4 S $3.46 $43,975 I/I (12,715) 149,736     -
   Swisher Daniel N Jr President and CEO   •       •      –    2015-07-24 4 OE $1.32 $43,976 I/I 33,315 153,974     -
   Ketchum Steven B Director   –       •      –    2015-07-24 4 S $3.46 $21,989 D/D (6,358) 84,259     -
   Ketchum Steven B Director   –       •      –    2015-07-24 4 OE $1.32 $21,986 D/D 16,656 86,378     -
   Bay City Capital Fund V Co-Investment Fund Lp 10% Owner   –       –       •   2015-07-24 4 S $3.46 $2,199,529 I/I (635,702) 5,623,815     -

  163 Records found
  1  2  3  4  5  6  7   
  Page 4 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed